Ustilago maydis produces itaconic acid via the unusual intermediate trans‐aconitate

Itaconic acid is an important biomass‐derived chemical building block but has also recently been identified as a metabolite produced in mammals, which has antimicrobial activity. The biosynthetic pathway of itaconic acid has been elucidated in the ascomycetous fungus A spergillus terreus and in human macrophages. In both organisms itaconic acid is generated by decarboxylation of the tricarboxylic acid (TCA) cycle intermediate cis‐aconitate. Here, we show that the basidiomycetous fungus U stilago maydis uses an alternative pathway and produces itaconic acid via trans‐aconitate, the thermodynamically favoured isomer of cis‐aconitate. We have identified a gene cluster that contains all genes involved in itaconic acid formation. Trans‐aconitate is generated from cis‐aconitate by a cytosolic aconitate‐Δ‐isomerase (Adi1) that belongs to the PrpF family of proteins involved in bacterial propionate degradation. Decarboxylation of trans‐aconitate is catalyzed by a novel enzyme, trans‐aconitate decarboxylase (Tad1). Tad1 displays significant sequence similarity with bacterial 3‐carboxy‐cis,cis‐muconate lactonizing enzymes (CMLE). This suggests that U . maydis has evolved an alternative biosynthetic pathway for itaconate production using the toxic intermediate trans‐aconitate. Overexpression of a pathway‐specific transcription factor (Ria1) or a mitochondrial tricarboxylic acid transporter (Mtt1) resulted in a twofold increase in itaconate yield. Therefore, our findings offer new strategies for biotechnological production of this valuable biomass‐derived chemical.